Levi & Korsinsky, LLP
CLASS ACTION UPDATE for UI, ATHA and QFIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
UI Shareholders Click Here: https://www.zlk.com/pslra-1/ubiquiti-inc-loss-of-submission-form?prid=17713&wire=1
ATHA Shareholders Click Here: https://www.zlk.com/pslra-1/athira-pharma-inc-loss-submission-form?prid=17713&wire=1
QFIN Shareholders Click Here: https://www.zlk.com/pslra-1/360-digitech-inc-loss-submission-form?prid=17713&wire=1
* ADDITIONAL INFORMATION BELOW *To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Ubiquiti Inc. (NYSE:UI)
UI Lawsuit on behalf of: investors who purchased January 11, 2021 - March 20, 2021
Lead Plaintiff Deadline : July 19, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/ubiquiti-inc-loss-of-submission-form?prid=17713&wire=1
According to the filed complaint, during the class period, Ubiquiti Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had downplayed the data breach in January 2021; (2) attackers had obtained administrative access to Ubiquiti's servers and obtained access to, among other things, all databases, all user database credentials, and secrets required to forge single sign-on (SSO) cookies; (3) as a result, intruders already had credentials needed to remotely access Ubiquiti's customers' systems; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Athira Pharma, Inc. (NASDAQ:ATHA)
This lawsuit is on behalf of investors who purchased Athira Pharma, Inc. (NASDAQ: ATHA) between September 18, 2020 and June 17, 2021 and/or purchased common stock in or traceable to the Company's registration statement issued in connection with the Company's September 2020 initial public offering priced at $17.00 per share.
Lead Plaintiff Deadline : August 24, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/athira-pharma-inc-loss-submission-form?prid=17713&wire=1
According to the filed complaint, (1) the research conducted by Defendant Kawas, which formed the foundation for Athira's product candidates and intellectual property, was tainted by Kawas' scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.
360 DigiTech, Inc. (NASDAQ:QFIN)
QFIN Lawsuit on behalf of: investors who purchased April 29, 2021 - July 7, 2021
Lead Plaintiff Deadline : September 13, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/360-digitech-inc-loss-submission-form?prid=17713&wire=1
According to the filed complaint, during the class period, 360 DigiTech, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had been collecting personal information in violation of relevant People's Republic of China laws and regulations; (ii) accordingly, 360 DigiTech was exposed to an increased risk of regulatory scrutiny and/or enforcement action; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
BioInvent International25.10.2021 13:47:06 CEST | Press release
BioInvent Appoints Immunotherapy Expert Alexander Eggermont to Scientific Advisory Board
Promore Pharma25.10.2021 09:21:54 CEST | Press release
Promore Pharma Announces that Scientific Article has Been Published on Clinical Study Results with Ropocamptide for Venous Leg Ulcers
Smart Eye22.10.2021 08:51:53 CEST | Press release
Interim Report January - September 2021
CTT Systems AB21.10.2021 15:03:07 CEST | Press release
Changes in the Nomination Committee for CTT Systems AB
ITOCO Inc.21.10.2021 13:32:20 CEST | Press release
ITOCO Welcomes Maria Teresa Tattersfield Yarza to Its Board of Directors and Carbon Credit Advisory Board
XVIVO Perfusion AB21.10.2021 08:06:47 CEST | Press release
XVIVO Presents Interim Report January-September 2021
Ximen Mining Corp.21.10.2021 05:31:49 CEST | Press release
Ximen Mining Corp Closes Recently Announced Financings
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom